Kania Flashcards

1
Q

List the common opportunistic infections (OIs) that can occur in patients with human immunodeficiency virus (HIV) infection.

A
  • Candida
  • Cryptococcus neoformans
  • Histoplasmosis
  • Disseminated Mycobacterium avium complex disease (MAC)
  • Pneumocystis pneumonia (PJP)
  • Toxoplasma encephalitis
  • Tuberculosis
  • Cytomegalovirus (CMV) retinitis

These infections are often associated with immunocompromised states, particularly in HIV patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical manifestations of oropharyngeal Candida infection?

A
  • Painless creamy white, plaque-like lesions on tongue or in mouth
  • Dry mouth
  • Taste alterations

These symptoms typically indicate an opportunistic infection in HIV patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical manifestations of esophageal Candida infection?

A
  • Common with oropharyngeal Candida
  • Fever
  • Retrosternal burning pain or discomfort
  • Dysphagia
  • Odynophagia
  • Lesions down esophagus

Esophageal involvement is a more severe form of Candida infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical manifestations of vulvovaginal Candida infection?

A
  • White, thick discharge
  • Vaginal itching
  • Burning

This form of Candida infection is common in women with HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the symptoms of Cryptococcus neoformans infection?

A
  • Meningitis symptoms
  • Neck stiffness
  • Photophobia
  • Increased intracranial pressure (ICP)

These are serious manifestations that may require immediate medical attention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the common clinical manifestations of Histoplasmosis?

A
  • Asymptomatic and self-limited pulmonary disease
  • Fever
  • Weight loss

Often seen in individuals exposed to bird droppings or working in specific environments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical features of Mycobacterium avium complex (MAC) infection?

A
  • Disseminated multi-organ infection
  • Night sweats
  • Weight loss
  • Fever
  • Diarrhea
  • Malaise/fatigue

These symptoms indicate advanced disease and are common in late-stage HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the symptoms of Pneumocystis jirovecii pneumonia (PJP)?

A
  • Dyspnea
  • Fever
  • Non-productive cough
  • Chest discomfort that worsens over weeks
  • Hypoxemia (pO2 <70)
  • Elevated LDH >500

PJP is a critical infection often seen in patients with a significantly compromised immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical manifestations of Toxoplasma gondii infection?

A
  • Focal encephalitis
  • Headache
  • Focal neurological deficits
  • Fever
  • Coma and seizures in progression
  • MRI shows ring-enhancing lesions in gray matter

This infection can lead to severe neurological complications in immunocompromised patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define primary prophylaxis of opportunistic infections (OIs).

A

Administration of anti-infective to prevent first episode of an OI in a patient living with HIV based on CD4 count.

This is crucial in managing the health of HIV patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define secondary prophylaxis of opportunistic infections (OIs).

A

Administration of anti-infective to prevent further reoccurrences of an OI in a patient with HIV after treatment for OI.

This helps prevent relapse in patients previously treated for OIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should primary prophylaxis for Mycobacterium avium complex (MAC) be initiated?

A

CD4 count <50 AND not receiving ART or ART not working

Early intervention can prevent MAC onset in at-risk patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the preferred anti-infective therapy for prophylaxis treatment of Mycobacterium avium complex (MAC)?

A

Azithromycin 1,200 mg PO once weekly

This regimen is effective for preventing MAC in HIV patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When can prophylactic anti-infective therapy for Mycobacterium avium complex (MAC) be discontinued?

A

Patient continuing on suppressive ART regimen

Continuous ART can help maintain the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is used for secondary prophylaxis of MAC and when do we restart

A

clarithromycin 500 mg BID + ethambutol 15mg/kg PO daily +/- rifabutin 300 mg PO daily (or azithro)

restart if CD4 <100
continue on treatment till CD4 >100 x 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when should primary prophylaxis begin in PJP

A

CD4 <100-200 if HIV RNA detectable
CD4 <100 regardless HIV RNA

17
Q

What is the preferred anti-infective therapy for Pneumocystis jirovecii pneumonia (PJP) prophylaxis?

A
  • TMP-SMX DS or SS PO daily
  • TMP-SMX DS PO MWF
  • Atovaquone 1500 mg PO daily with food
  • Dapsone 100 mg PO daily
  • Pentamidine 300 mg IV monthly

These options provide multiple alternatives for PJP prophylaxis.

18
Q

When can prophylactic anti-infective therapy for PJP be discontinued?

A

CD4 count >200 for >3 months on ART or CD4 count >100 if HIV RNA suppressed for >3 months

Monitoring CD4 counts is essential in managing HIV.

19
Q

secondary prophylaxis in PJP and when to restart

A

Bactrim DS or SS PO daily
restart if CD4 < 100

20
Q

When should primary prophylaxis for Toxoplasma gondii be initiated?

A

Toxoplasma IgG positive with CD4 count <100

This identifies patients at high risk for Toxoplasma infections.

21
Q

What is the preferred anti-infective therapy for prophylaxis of Toxoplasma gondii?

A

TMP-SMX DS PO daily

This treatment is standard for preventing Toxoplasma in immunocompromised patients.

22
Q

When can prophylactic anti-infective therapy for Toxoplasma gondii be discontinued?

A

CD4 count >200 for >3 months on ART or CD4 count >100 and HIV RNA suppressed >3 months

Monitoring is crucial for determining treatment duration.

23
Q

secondary prophylaxis for toxoplamsa gondii, when do we stop and restart

A

stop when CD4 > 200 x 6 months
restart if CD4 <200

24
Q

What is the preferred anti-infective therapy for oropharyngeal Candida infection?

A
  • Fluconazole 200 mg load then 100-200 mg PO daily x 7-14 days
  • Nystatin suspension 100,000 units/mL 5 mL swish and swallow QID x 7-14 days
  • Clotrimazole troches 10 mg 5 times/day for 7-14 days

These treatments are effective for managing Candida infections.

25
Q

What is the preferred anti-infective therapy for esophageal Candida infection?

A

Fluconazole 200 mg load then 200-400 mg IV or PO daily x 14-21 days

This regimen is necessary for treating more severe Candida infections.

26
Q

What is the preferred treatment for vulvovaginal Candida infections?

A
  • Uncomplicated: fluconazole 150 mg PO one dose
  • Topical azoles for 3-7 days
  • Severe: fluconazole 100-200 mg PO daily x >7 days
  • Azole refractory: boric acid 600 mg vaginal suppository daily x 14 days

Different treatments are tailored based on the severity of the infection.

27
Q

What is the treatment regimen for Mycobacterium avium complex (MAC) infection?

A
  • Clarithromycin 500 mg PO BID + ethambutol 15 mg/kg PO daily x 12 months
  • Azithromycin 500-600 mg PO daily + ethambutol 15 mg/kg PO daily (if intolerant to clarithromycin)
  • Rifabutin 300 mg PO daily if severe
  • Add a 4th drug if high risk mortality
  • levofloxacin, moxifloxacin, amikacin, strepto, linez

Early aggressive treatment is crucial for managing MAC infections.

28
Q

What is the treatment for moderate-severe Pneumocystis jirovecii pneumonia (PJP)?

A
  • Trimethoprim-sulfamethoxazole 15-20 mg/kg/day IV of TMP q6-8h x 21 days
  • Primaquine 30 mg PO once daily + clindamycin
  • Pentamidine 4 mg/kg IV once daily infused over 1 hr
  • Prednisone 40 mg PO BID x 5 days then 40 mg daily x 5 days then 20 mg daily x 11 days (if pO2 < 70)

This treatment is essential for managing severe cases of PJP.

29
Q

what is the treatment for mild-moderate PJP?

A

Bactrim 15-20 mg/kg/day trimethoprim in TID
Bactrim DS TID
alt:
dapsone 100 mg daily
primaquine 30 mg daily +TMP 15mg/kg/day
atovaquone 750 mg BID

30
Q

G6PD should be checked before which drugs

A

dapsone
primaquine

31
Q

What is the treatment for Toxoplasma gondii acute infection?

A
  • Pyrimethamine 200 mg PO x 1 followed by weight-based dosing x 6 weeks
  • BW < 60 kg: pyrimethamine 50 mg PO daily + sulfadiazine 1000 mg PO q6h + leucovorin 10-25 mg PO daily
  • BW > 60 kg: pyrimethamine 75 mg PO daily + sulfadiazine 1000 mg PO q6h + leucovorin 10-25 mg PO daily
    or TMP-SMX5 mg/kg trimethoprim IV or PO BID x 6 weeks

This regimen is critical for treating acute Toxoplasma infections.

32
Q

What is the treatment for chronic Toxoplasma gondii infection?

A
  • Pyrimethamine 25-50 mg PO daily + sulfadiazine 2000-4000 mg PO daily + leucovorin 10-25 mg PO daily
  • TMP-SMX DS PO BID

This treatment is necessary for managing chronic infections.

33
Q

What is the treatment regimen for Cryptococcus neoformans infection?

A
  • Induction: Amphotericin B 3-4 mg/kg IV once daily + flucytosine 25 mg/kg PO QID x 2 weeks
  • Consolidation: Fluconazole 400-800 mg PO daily x 8 weeks
  • Maintenance: Fluconazole 200 mg PO daily x 1 year or longer

The treatment phases are critical for managing cryptococcal meningitis.

34
Q

What is the treatment for mild-moderate Histoplasmosis?

A

Itraconazole 200 mg PO TID x 3 days then BID x 1 year

This regimen is used for less severe cases of Histoplasmosis.

35
Q

What is the treatment for severe Histoplasmosis?

A
  • Liposomal amphotericin B 3 mg/kg IV daily x 2 weeks
  • Then itraconazole 200 mg PO TID x 3 days then BID x 1 year

Severe cases require more aggressive treatment.

36
Q

What is the primary prophylaxis for Histoplasmosis?

A

CD4 count <150 and at high risk due to occupational exposure; Itraconazole 200 mg PO daily

Prophylaxis is crucial for individuals at high risk of exposure.

37
Q

What is the secondary prophylaxis for Histoplasmosis?

A

Continuation of maintenance therapy after 1 year; Itraconazole 200 mg PO daily

This helps prevent relapse in patients previously treated for Histoplasmosis.